Illmer T, Schaich M, Ehninger G, Thiede C. Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemias. Haematologica [Internet]. 2007Jan.1 [cited 2026Nov.15];92(1):137-8. Available from: https://haematologica.org/article/view/4295